These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11084078)

  • 1. Increasing incidence and pretransplantation screening of hepatocellular carcinoma.
    Everson GT
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S2-10. PubMed ID: 11084078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D; Han KH; Chan HL; Ueno Y;
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis and hepatocellular carcinoma.
    Sallie R; Di Bisceglie AM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model.
    Saab S; Ly D; Nieto J; Kanwal F; Lu D; Raman S; Amado R; Nuesse B; Durazo F; Han S; Farmer DG; Ghobrial RM; Yersiz H; Chen P; Schwegel K; Goldstein LI; Tong M; Busuttil RW
    Liver Transpl; 2003 Jul; 9(7):672-81. PubMed ID: 12827551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance and diagnosis for hepatocellular carcinoma.
    Aljabiri MR; Lodato F; Burroughs AK
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S2-12. PubMed ID: 17969087
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?
    Roayaie S; Llovet JM
    Clin Liver Dis; 2005 May; 9(2):315-28. PubMed ID: 15831276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of hepatocellular carcinoma.
    Duffy JP; Hiatt JR; Busuttil RW
    Cancer J; 2008; 14(2):100-10. PubMed ID: 18391615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers.
    Iizuka N; Oka M; Sakaida I; Moribe T; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Yamashita S; Okita K; Sakata K; Karino Y; Toyota J; Ando E; Ide T; Sata M; Tsunedomi R; Tsutsui M; Iida M; Tokuhisa Y; Sakamoto K; Tamesa T; Fujita Y; Hamamoto Y
    Clin Chim Acta; 2011 Jan; 412(1-2):152-8. PubMed ID: 20883676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
    Lin OS; Keeffe EB; Sanders GD; Owens DK
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
    Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
    Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].
    Nagoshi S; Fujiwara K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):615-8. PubMed ID: 15359871
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver transplantation in patients with hepatocellular carcinoma.
    Schwartz M
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S81-5. PubMed ID: 14762845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical therapy of hepatic fibrolamellar carcinoma].
    Meriggi F; Forni E
    Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can hepatocellular cancer screening increase the proportion of long-term survivors?
    Gannon CJ; Izzo F; Aloia TA; Pignata S; Nasti G; Vallone P; Orlando R; Scordino F; Curley SA
    Hepatogastroenterology; 2009; 56(93):1152-6. PubMed ID: 19760960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers for hepatocellular carcinoma].
    Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R
    Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.